Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention.

AIDS
Ariane van der StratenDavid R Bangsberg

Abstract

Although the balance of recent evidence supports the efficacy of antiretroviral (ARV)-based pre-exposure prophylaxis (PrEP) against HIV-1 infection, recent negative trial results are perplexing. Of seven trials with available HIV endpoints, three different products have been tested: tenofovir 1% vaginal gel, oral tenofovir disoproxil fumarate (TDF) tablets, and TDF/emtricitabine tablets. Six of these trials were conducted exclusively in sub-Saharan Africa; all found the products to be well tolerated, and four demonstrated effectiveness. Furthermore, the HIV Prevention Trial Network (HPTN) 052 trial recently confirmed that antiretroviral treatment leads to 96% reduction in transmission to HIV-negative partners in HIV-serodiscordant couples. These results, along with human and animal data, provide substantial evidence for the efficacy of antiretroviral-based HIV prevention. Yet assessment of oral TDF/emtricitabine in the FEM-PrEP study and of oral and vaginal tenofovir in the Microbicide Trial Network (MTN)-003 trial (VOICE) was stopped for futility. How do we make sense of these discrepant results? We believe that adherence is a key factor, although it cannot be the only factor. Expanding upon a recent editorial in the Lancet, w...Continue Reading

References

Aug 1, 1989·Clinical Pharmacology and Therapeutics·P RuddG Marshall
Dec 8, 2007·AIDS and Behavior·Steven D Pinkerton
May 10, 2008·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Shareen Y El-Ibiary, Jennifer M Cocohoba
Jun 4, 2008·AIDS·Laith J Abu-Raddad, Ira M Longini
Jul 16, 2008·Emerging Themes in Epidemiology·Helen A WeissLaith J Abu-Raddad
Jun 11, 2009·AIDS·Judith R GlynnHelen A Weiss
Nov 26, 2010·The New England Journal of Medicine·Robert M GrantUNKNOWN iPrEx Study Team
Dec 2, 2010·The Journal of Antimicrobial Chemotherapy·Peter L AndersonRobert M Grant
Jan 22, 2011·Science·Sten H Vermund, Lut Van Damme
Jun 10, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sue Napierala MavedzengeAriane Van Der Straten
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Jul 21, 2011·Lancet·Salim S Abdool Karim, Quarraisha Abdool Karim
Aug 24, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Elizabeth MontgomeryKristine Torjesen
Oct 7, 2011·The Lancet Infectious Diseases·Renee HeffronUNKNOWN Partners in Prevention HSV/HIV Transmission Study Team
Oct 12, 2011·Antimicrobial Agents and Chemotherapy·Jeremy NuttallJoseph Romano
Dec 14, 2011·Science Translational Medicine·Kristine B PattersonAngela D M Kashuba

❮ Previous
Next ❯

Citations

Oct 18, 2012·International Journal of Clinical Pharmacy·Christine Bruno, Parya Saberi
Mar 16, 2013·Current HIV/AIDS Reports·Jared M Baeten, Robert Grant
Aug 7, 2013·Current HIV/AIDS Reports·Deborah JonesRyan Cook
May 16, 2012·Proceedings of the National Academy of Sciences of the United States of America·Dan H BarouchJohn P Moore
Jul 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Craig S PaceDavid D Ho
Sep 1, 2012·AIDS Research and Human Retroviruses·Jose R Castillo-MancillaPeter L Anderson
Feb 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julie E Myers, Kent A Sepkowitz
Sep 22, 2012·The Journal of Infectious Diseases·Catherine A Blish
Oct 4, 2012·Current Opinion in HIV and AIDS·Lynn T MatthewsDeborah Cohan
Sep 26, 2012·Antimicrobial Agents and Chemotherapy·Todd J JohnsonPatrick F Kiser
Nov 2, 2012·Journal of Virology·Morgan ChateauJ Victor Garcia
May 16, 2013·BMC Infectious Diseases·Vincenzo PuroGiuseppe Ippolito
Nov 10, 2013·PloS One·Nabanita BiswasCharles R Wira
Apr 18, 2014·PloS One·Larisa KizimaJosé A Fernández-Romero
Apr 9, 2013·Journal of the International AIDS Society·Cynthia WoodsongSheena McCormack
Apr 1, 2014·Journal of the International AIDS Society·Daniel J EscuderoBrandon D L Marshall
Oct 17, 2013·International Journal of Clinical Pharmacy·Tanuja N GengiahLeila E Mansoor
Dec 10, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maile Y KarrisPhilip M Polgreen
Nov 20, 2013·AIDS and Behavior·Jacob J van den BergKathleen M Morrow
Apr 4, 2014·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Ana Penman-AguilarSamuel F Posner
Jun 14, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sheena M McCormackMyron S Cohen
Jan 17, 2013·AIDS and Behavior·Ariane van der StratenDonn M Dennis
Nov 28, 2012·Current HIV/AIDS Reports·Ariane van der StratenAlexandra Minnis
Jul 12, 2012·AIDS and Behavior·Ariane van der StratenCynthia Woodsong
May 24, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·K Rivet AmicoRobert Grant
May 24, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Christina PsarosSteve A Safren
Jul 14, 2012·AIDS and Behavior·Elizabeth T MontgomeryC Woodsong
Jan 10, 2013·Annual Review of Public Health·Steffanie A StrathdeeThomas L Patterson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.